The medtech industry has been slow to adapt to the rapid growth of lower-cost outpatient centers that are taking procedures out of hospitals, according to Brian Chapman, a consultant for ZS.
The shift of many types of interventional and surgical procedures from hospitals to outpatient settings like ambulatory surgical centers will compel medical device manufacturers to adjust their sales and marketing strategy, according to Brian Chapman, a principal with professional services firm ZS who specializes in medtech.
“Hospitals are already contending with overcapacity and rickety finances, and I think that this trend is going to hit big...
CEO Alexandre Chau told Medtech Insight that the Middle East and Africa presented the ideal mix of market potential, physician training opportunities, and regulatory readiness when the company was considering expansion markets beyond Europe and the US.
A recent approval from the US FDA allowing Boston Scientific to broaden its labeling for its pulse field ablation system means more patients with one type of AFib will have access to a promising new treatment.
Thena Capital, the first UK-based early-stage specialist medtech firm, has made its first investment since closing its £50m fund. Medtech Insight spoke with general partner Pamela Walker Geddes to gain insight into Thena Capital’s investment strategy.
